Skip to main content
SpringerLink
Log in

TGA issues new ADR reporting guidance for drug sponsors

  • Guideline
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • TGA - Therapeutic Goods Administration. Australian requirements and recommendations for pharmacovigilance responsibilities of sponsors of medicines. Internet Document : [41 pages], 13 Dec 2012. Available from: URL: http://www.tga.gov.au

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

TGA issues new ADR reporting guidance for drug sponsors. Reactions Weekly 1436, 2 (2013). https://doi.org/10.1007/s40278-013-0856-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-013-0856-4

Search

Navigation